NCT04367779
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting

Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: Child, Adult, Older Adult
Location of Metastases: Brain
Additional Notes: Patients must have at least one measurable lesion before receiving proton beam therapy
Exclusions: Patients previously treated with radiotherapy in the same site either with protons or photons
https://ClinicalTrials.gov/show/NCT04367779